Article Text

Download PDFPDF
Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction
  1. Hakan Özhan,
  2. Yakup Balaban
  1. Duzce University Düzce Medical School Department of Cardiology, Konuralp, Düzce, Turkey
  1. Correspondence to Dr Hakan Ozhan, Duzce Universitesi Düzce Tıp Fakültesi 81620 Konuralp Düzce Turkey; ozhanhakan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor: We read with interest, the featured editorial by Yip et al1 on heart failure with normal ejection fraction (HENEF). His comments on current studies of spironolactone in HENEF are encouraging since results with ACE inhibitors and AR blockers up to date were surprisingly negative.

We have investigated the …

View Full Text


  • Linked articles 195826.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the Duzce University Ethics committee.

  • Provenance and peer review Not commissioned; not externally peer reviewed.

Linked Articles